Veracyte traded at $25.62 this Tuesday August 9th, decreasing $1.21 or 4.51 percent since the previous trading session. Looking back, over the last four weeks, Veracyte lost 3.64 percent. Over the last 12 months, its price fell by 45.34 percent. Looking ahead, we forecast Veracyte to be priced at 27.13 by the end of this quarter and at 24.93 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
25.62
Daily Change
-4.51%
Yearly
-45.34%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agilent 130.03 -2.50 -1.88% -16.93%
Agenus 2.61 -0.04 -1.51% -51.67%
Anika Therapeutics 23.46 0.78 3.44% -42.32%
Arrowhead Research 47.02 1.06 2.31% -25.10%
Biocept 1.09 0.04 3.81% -73.54%
Bruker 62.16 -0.32 -0.51% -24.97%
Exact Sciences 46.81 -0.24 -0.51% -53.64%
Heron Therapeutics 3.79 0.22 6.16% -68.26%
Illumina 217.12 -5.86 -2.63% -57.12%
Immunogen 5.40 0.01 0.19% -4.93%
Karyopharm Therapeutics 5.17 0.01 0.19% -7.18%
Ligand Pharmaceuticals 103.22 3.97 4.00% -6.10%
Laboratory Of America 255.66 -0.15 -0.06% -15.25%
Myriad Genetics 26.34 -0.78 -2.88% -21.26%
Rigel Pharmaceuticals 1.43 -0.07 -4.36% -62.79%
Roche Holding 318.80 2.95 0.93% -12.62%
Sangamo BioSciences 5.18 -0.11 -2.06% -47.67%
Sonic Healthcare 34.87 -0.01 -0.03% -15.08%
Siemens 106.62 -2.78 -2.54% -23.41%
Thermo Fisher Scientific 582.22 -1.73 -0.30% 7.74%
Veracyte 25.62 -1.21 -4.51% -45.34%
Waters 327.47 -4.69 -1.41% -17.07%
Intrexon 2.35 0.30 14.63% -61.09%

Indexes Price Day Year
USND 12476 -168.73 -1.33% -15.64%
US2000 1914 -26.98 -1.39% -14.52%

Veracyte
Veracyte, Inc. is a genomic diagnostics company. The Company, through its scientific platform, which utilizes ribonucleic acid (RNA), whole-transcriptome sequencing combined with machine learning, produces genomic tests. It provides various genomic tests, including Afirma Genomic Sequencing Classifier (GSC), Percepta Bronchial Genomic Classifier, Envisia Genomic Classifier and Afirma Xpression Atlas. It provides GSC tests for thyroid cancer. It provides Percepta Bronchial Genomic Classifier tests for lung cancer. It provides Envisia Genomic Classifier tests for idiopathic pulmonary fibrosis (IPF). Its Afirma Xpression Atlas provides information on gene alterations associated with thyroid cancer, enabling physicians to tailor surgical and treatment decisions at time of diagnosis.